The cancellation or postponement of elective procedures, including breast augmentations and reconstructions, due to the COVID-19 pandemic will have a major negative impact on the European market for breast implants and reconstructive devices in the short term, compounding the recent market decline due to the association of BIA-ALCL with macrotextured silicone breast implants. However, the market will return to growth, supported by continued patient demand for augmentation and reconstruction procedures, innovative technologies that improve the ease of implant placement, and efforts by companies to address concerns regarding product safety.  

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for breast implants and reconstructive devices in Europe across a 10-year period.


The COVID-19 pandemic will negatively affect the breast implant and reconstructive device market.

To what extent will COVID-19 impact the breast implant and reconstructive device market?

Which procedures will be impacted the most?

How quickly will procedure volumes rebound?

Subsequent to initial declines, the market for breast implants and reconstructive devices will grow in most European countries through 2028.

What factors will limit growth in this market, and which countries will experience hindered growth?

What are the current trends in product innovation and how strongly will they impact the market in the coming years?

This market has been negatively impacted by safety concerns, such as BIA-ALCL and the associated recall of textured breast implants.

How has BIA-ALCL affected the European breast implant and reconstructive device market?

How has the recall of textured breast implants impacted market growth across Europe?

What strategies are manufacturers pursuing to address these safety concerns?

Table of contents

  • Europe
    • Abstract
    • Executive Summary
      • COVID-19 Updates
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • COVID-19 Analysis
      • Market Impact
      • Guidance and Recommendations
      • Industry and Clinician Perspectives
      • Major Market Forecast Changes and Assumptions
      • Competitive Impact
    • Breast Implant and Reconstructive Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Physician Training and Marketing
        • Pricing Strategies and Purchasing Options
        • Product Recalls and Safety Issues
        • Product Portfolio Management
        • Distribution and Sales Network
        • Regulatory Environment
        • Patient Marketing and Awareness
        • Clinical Data
        • Product Improvements and Innovations
        • Domestic Competitors
      • Market Developments
    • Breast Implant Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Silicone
        • Saline
      • Competitive Highlights
      • Select Competitors
      • Competitive Factors and Strategies
    • Tissue Expander Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Select Competitors
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Attusa K. Chikodi, MBA

Attusa K. Chikodi is a Senior Analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at DRG (Part of Clarivate)  specializing in the  Aesthetics market. Attusa has done her MBA in pharmaceutical management from Narsee Monjee Institute of Management Studies and Bachelors in Industrial Microbiology


Related Reports

Breast Implants and Reconstructive Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for breast implants and reconstructive devices will be supported by innovative technologies that improve the ease of implant placement as well as efforts by companies to...

View Details

Breast Implants and Reconstructive Devices | Medtech 360 | Market Insights | United States

The US market for breast implants and reconstructive devices will grow moderately through 2026, driven primarily by an increasing number of aesthetically conscious patients in the country, new p...

View Details